Biomarkers for Early Detection and Screening in Pancreatic Cancer Highlights from the “ 45 th ASCO Annual Meeting ”

@inproceedings{Hoimes2009BiomarkersFE,
  title={Biomarkers for Early Detection and Screening in Pancreatic Cancer Highlights from the “ 45 th ASCO Annual Meeting ”},
  author={Christopher J Hoimes and Matthew T. Moyer and Muhammad Wasif Saif},
  year={2009}
}
Author Tool/Marker Comments #4613 [10] Gold D, et al. Monoclonal antibody: PAM4 • PAM4 is an IgG1 antibody originally generated against mucin from a RIP1 murine pancreatic cancer xenograft [11]. • PAM4 identifies a “unique antigen” in precursor and neoplasia lesions. • Abstract does not specify the cancer cell's epitope or target; unclear if it has been characterized. #4624 [12] Ho AS, et al miR-210 • miR-210 is an endothelial localized pro-angiogenic microRNA. • miR-210 responds to hypoxia… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Comparative yield of endosonography and magnetic resonance imaging in individuals at high-risk for pancreatic cancer

  • F Harinck, I Kluijt, JW Poley, A Cats, CM Aalfs, DJ Gouma
  • Gastroenterology
  • 2009
1 Excerpt

Similar Papers

Loading similar papers…